Suppr超能文献

类风湿关节炎和骨关节炎中的滑膜组织学与免疫病理学。抗风湿药物的体内作用。

Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs.

作者信息

Haraoui B, Pelletier J P, Cloutier J M, Faure M P, Martel-Pelletier J

机构信息

Rheumatic Disease Unit, Notre-Dame Hospital Research Center, Montreal, Quebec, Canada.

出版信息

Arthritis Rheum. 1991 Feb;34(2):153-63. doi: 10.1002/art.1780340205.

Abstract

We examined the histologic and immunopathologic features of the synovial membrane of 18 patients with rheumatoid arthritis (RA) and 12 patients with osteoarthritis (OA) who had undergone total knee arthroplasty. Patients were classified into 5 groups according to therapeutic regimen and disease: RA treated with nonsteroidal antiinflammatory drugs (NSAIDs), RA treated with NSAIDs and prednisone, RA treated with NSAIDs and methotrexate (MTX), OA treated with analgesics, and OA treated with NSAIDs. There were no significant between-group differences in the percentages or the distribution pattern of the infiltrating T cell subsets (CD4, CD8), HLA-DR, or interleukin-2 receptor-bearing cells. However, inflammatory indices, which included the thickness of the lining cell layer and the density of the mononuclear cell infiltrate, were significantly higher in the RA patients treated with prednisone and those treated with MTX (P less than 0.05). Similarly, fibrosis was markedly reduced in these 2 groups. The RA patients treated with NSAIDs alone and the 2 groups of patients with OA demonstrated similar profiles. These data suggest that prednisone and MTX may inhibit the development of fibrosis without altering the subsets of the inflammatory cell population. This observation raises the possibility that the action of these 2 drugs may be partly mediated by the suppression of inflammatory mediators that are responsible for fibroblast activation.

摘要

我们检查了18例类风湿关节炎(RA)患者和12例骨关节炎(OA)患者行全膝关节置换术后滑膜的组织学和免疫病理学特征。根据治疗方案和疾病将患者分为5组:用非甾体抗炎药(NSAIDs)治疗的RA、用NSAIDs和泼尼松治疗的RA、用NSAIDs和甲氨蝶呤(MTX)治疗的RA、用镇痛药治疗的OA以及用NSAIDs治疗的OA。浸润性T细胞亚群(CD4、CD8)、HLA-DR或携带白细胞介素-2受体细胞的百分比及分布模式在组间无显著差异。然而,包括衬里细胞层厚度和单核细胞浸润密度在内的炎症指标,在用泼尼松治疗的RA患者和用MTX治疗的患者中显著更高(P小于0.05)。同样,这两组中的纤维化明显减轻。单用NSAIDs治疗的RA患者和两组OA患者表现出相似的特征。这些数据表明,泼尼松和MTX可能抑制纤维化的发展而不改变炎症细胞群体的亚群。这一观察结果增加了这两种药物的作用可能部分由抑制负责成纤维细胞活化的炎症介质介导的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验